(Updated - December 15, 2022 4:00 AM EST)

Goldman Sachs analyst Andrea Tan initiates coverage on Fate Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE